Structured evidence table for Taurine Blood Lipids Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Taurine Blood Lipids Randomized Trial | As life expectancy increases, age-associated declines in muscle strength, metabolic flexibility, immune responsiveness, and cognitive resilience have become major contributors to morbidity and diminished quality of life. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Blood Lipids Randomized Trial | Despite these benefits, the biological response to exercise is often dampened in aging due to reduced mitochondrial efficiency, lower anabolic sensitivity, impaired antioxidant capacity, and chronic inflammatory signaling. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Blood Lipids Randomized Trial | As a result, older adults commonly experience delayed recovery, attenuated gains in muscle strength or aerobic capacity, and limited adaptations compared with younger individuals. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Blood Lipids Randomized Trial | Kirkwood, 2005 Lutz and Quinn, 2012 Falahi et al., 2025 Liang et al., 2022 Hébert, 1997 The steady growth of the global older population has intensified scientific attention toward biological processes that erode functional capacity and compromise independence with aging. | 3 | Chen Zhigang (2026) | Taurine and glutamine supplementation in aging: systemic mechanisms, exercise interactions, and modulation of muscular and neurobiological pathways |
| Taurine Blood Lipids Randomized Trial | Interventions that alter metabolite availability or metabolism, such as caloric restriction (CR) or reduced insulin/IGF‐1 signaling (IIS), extend lifespan across species (Gao et al. ). | 3 | Jiang Yizhou (2026) | Lifespan‐Extending Endogenous Metabolites |
| Taurine Blood Lipids Randomized Trial | This review highlights the role of endogenous metabolites in regulating longevity pathways and evaluates evidence across species to aid understanding metabolic regulation of aging and guiding future investigations. | 3 | Jiang Yizhou (2026) | Lifespan‐Extending Endogenous Metabolites |
| Taurine Blood Lipids Randomized Trial | In UVB‐irradiated hairless mice, oral taurine preserved epidermal moisture and significantly reduced wrinkle formation, suggesting an anti‐photoaging action via its osmolyte and moisturizing roles (Yoshimura et al. ). | 3 | Jiang Yizhou (2026) | Lifespan‐Extending Endogenous Metabolites |
| Taurine Blood Lipids Randomized Trial | 2023 2018 2021 2025 2013 Aging is a multifactorial process driven by the interplay of genetic, environmental, and metabolic perturbations, with dysregulated nutrient sensing and metabolic dysfunction recognized as core hallmarks (Lopez‐Otin et al. ). | 3 | Jiang Yizhou (2026) | Lifespan‐Extending Endogenous Metabolites |
Source documents